Does informing people who inject drugs of their hepatitis C status influence their injecting behavior? Analysis of the Networks II study

QR Code

Does informing people who inject drugs of their hepatitis C status influence their injecting behavior? Analysis of the Networks II study

Background: People who inject drugs (PWID) are at risk of hepatitis C virus (HCV). It is plausible that PWID who receive a diagnosis of HCV will reduce their injecting risk out of concern for their injecting partners, although evidence for this is currently limited. The aim of this study was to inve...

Full description

Bibliographic Details
Main Authors:	Aspinall, E., Weir, A., Sacks-Davis, R., Spelman, T., Grebely, J., Higgs, Peter, Hutchinson, S., Hellard, M.
Format:	Journal Article
Published:	Elsevier BV 2014
Subjects:	Risk behaviours Diagnosis Hepatitis C virus Testing People who inject drugs
Online Access:	http://hdl.handle.net/20.500.11937/16813

Similar Items

The ins and outs of injection in Western Australia
by: Carruthers, Susan
Published: (2003)

Co-infections of hepatitis B patients with other hepatitis viruses and their serological, biological and prognostic markers
by: Hudu Abdullahi, Shuaibu
Published: (2017)

Concordance between self-reported and actual hepatitis C virus infection status in a cohort of people who inject drugs
by: O’Keefe, D., et al.
Published: (2013)

Preventing hepatitis C virus transmission among young people in the justice system
by: Lenton, E., et al.
Published: (2013)

Comorbities and medications of patients with chronic hepatitis C under specialist care in the UK
by: Hudson, Benjamin, et al.
Published: (2017)

Risk factors for hepatitis c virus infection among adult patients at a public hospital in Kedah, Malaysia
by: Mohd Suan, Mohd Azri
Published: (2019)

Molecular epidemiology and antiviral resistance characterization of Hepatitis C virus circulating in Africa and Brazil
by: Adeboyejo, Kazeem Adeyinka
Published: (2020)

Detection of HCV-specific IFN-gamma responses in HCV antibody and HCV RNA negative injecting drug users
by: Flynn, J., et al.
Published: (2014)

Availability of HIV prevention and treatment services for people who inject drugs: Findings from 21 countries
by: Petersen, Z., et al.
Published: (2013)

Hepatic elastin content is predictive of adverse outcome in advanced fibrotic liver disease
by: Kendall, Timothy, et al.
Published: (2018)

Recombinant human L-ficolin directly neutralizes hepatitis C virus entry
by: Hamed, Mohamed R., et al.
Published: (2014)

The Australian Study of HIV and Injecting Drug Use. Part I: Prevalence for HIV, hepatitis B and hepatitis C among injecting drug users in four Australian cities
by: Loxley, Wendy, et al.
Published: (1997)

The Australian Study of HIV and Injecting Drug Use. Part 11: Predicting exposure to hepatitis C and hepatitis B
by: Carruthers, Susan, et al.
Published: (1997)

Investigation of Hepatitis B virus entry mechanism
by: Raymond, Chidinma
Published: (2022)

Effectiveness of an education intervention on Hepatitis C treatment adherence among Libyan patients in a medical center in Tripoli
by: Adam, Samia Ibrahim Mohamed
Published: (2018)

Novel entry pathways for Hepatitis B virus
by: Parmar, Devan
Published: (2023)

Authenticity and Diversity: Enhancing Australian Hepatitis C Prevention Messages
by: Winter, R., et al.
Published: (2013)

Display of the pres regions of the surface antigen of Hepatitis B virus on M13 and T7 Bactetiophages
by: Kok, Wai Ling
Published: (2001)

Barriers to receiving hepatitis c treatment for people who inject drugs myths and evidence
by: Higgs, Peter, et al.
Published: (2011)

Development and characterization of a human monoclonal antibody targeting the N-terminal region of hepatitis C virus envelope glycoprotein E1
by: Mesalam, Ahmed Atef, et al.
Published: (2018)

The missing mass of morality: A new fitpack design for hepatitis C prevention in sexual partnerships
by: Fraser, Suzanne
Published: (2013)

The impact of injecting networks on hepatitis C transmission and treatment in people who inject drugs
by: Hellard, M., et al.
Published: (2014)

Host genetic factors associated with hepatocellular carcinoma in patients with hepatitis C virus infection: a systematic review
by: Walker, Alex J., et al.
Published: (2018)

Expression, purification and structural characterisation of Hepatitis B virus core antigen with an N-terminal extension
by: Yoon, Kam Yee
Published: (2013)

The effects of the human innate pattern recognition receptor L-ficolin and its variants against Hepatitis C virus infection
by: Mason, Christopher Paul
Published: (2019)

Development of anti-hepatitis B virus core antigen biosensor using gold nanoparticle-decorated reduced graphene oxide
by: Abd Muain, Mohamad Farid
Published: (2019)

Selection of High Affinity Peptides Against Hepatitis B Core Antigen from a Phage-Displayed Cyclic Peptide Library
by: Ho, Kok Lian
Published: (2002)

Hepatitis C Virus Phylogenetic Clustering Is Associated with the Social-Injecting Network in a Cohort of People Who Inject Drugs
by: Sacks-Davis, R., et al.
Published: (2012)

Canine idiopathic chronic hepatitis
by: Bexfield, Nicholas
Published: (2017)

Outcomes after successful direct acting antiviral therapy for patients with chronic hepatitis C and decompensated cirrhosis
by: Cheung, Michelle C.M., et al.
Published: (2016)

Harm reduction and hepatitis C: On the ethics and politics of prevention and treatment
by: Fraser, S., et al.
Published: (2011)

Hepatitis C treatment - better outcomes through partner support
by: Chapman, Fleur, et al.
Published: (2012)

High Rates of Hepatitis C Virus Reinfection and Spontaneous Clearance of Reinfection in People Who Inject Drugs: A Prospective Cohort Study
by: Sacks-Davis, R., et al.
Published: (2013)

The relationship between age and risky injecting behaviours among a sample of Australian people who inject drugs
by: Horyniak, Danielle, et al.
Published: (2013)

"Petunias too, please": further thoughts on achieving control of hepatitis C in Australia
by: Loxley, Wendy
Published: (1997)

Recombinant hepatitis B virus core particles: association, dissociation and encapsidation of green fluorescent protein.
by: Lee, Khai Wooi, et al.
Published: (2008)

An evaluation of the opt-out approach to Hepatitis C Virus infection testing in prisons
by: Jack, Kathryn
Published: (2020)

Hepatitis B capsid as a delivery vehicle into mammalian cells
by: Lee, Khai Wooi
Published: (2012)

Molecular characterization and methylation status of torque teno virus isolation among hepatitis patients in a public hospital in Pahang, Malaysia
by: Hazanuddin, Siti Nurzulaikha
Published: (2020)

The cost of treatment failure: resource use and costs incurred by hepatitis C virus genotype 1-infected patients who do or do not achieve sustained virological response to therapy
by: Backx, M., et al.
Published: (2014)